U.S. Drugmaker to Halt MMR Vaccine Supplies to Russia – Kommersant

INSUBCONTINENT EXCLUSIVE:
The U.S
drugmaker MSD will stop supplying Russia with vaccines against measles, mumps, rubella and chickenpox, the Kommersant business dailyreported
Monday.MSD had informed a number of its contractors to stop supplying its Varivax chickenpox vaccine and the M-M-R II vaccine to Russia, the
nearly one-fifth of chickenpox vaccines in Russia, with 2021 sales amounting to 162.8 million rubles ($3 million)
according to Kommersant.Eleven of its vaccines that have Russian analogues accounted for less than 50% of sales in Russia last year, Nikolai
Bespalov, development director of the RNC Pharma consultancy, told the outlet.MSD can halt vaccine supplies one year after notifying the
which is known as Merck - Co
in North America, will reportedly continue sales of drugs that have no analogues in Russia.Western pharmaceutical giants such as Pfizer,
previously reported that Russia was running low on medical supplies produced abroad following a wave of crippling Western sanctions and
international brand exits from the market.